Gruden, G., Bruno, G., Chaturvedi, N., Burt, D., Pinach, S., Schalkwijk, C., Stehouwer, C. D., Witte, D. R., Fuller, J. H., & Cavallo Perin, P. (2009). ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. Journal of Internal Medicine, 266(6), 527-536. https://doi.org/10.1111/j.1365-2796.2009.02129.x

Gaens, K. H., Ferreira, I., van der Kallen, C. J., van Greevenbroek, M. M., Blaak, E. E., Feskens, E. J., Dekker, J. M., Nijpels, G., Heine, R. J., 't Hart, L. M., de Groot, P. G., Stehouwer, C. D., & Schalkwijk, C. G. (2009). Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.Journal of Clinical Endocrinology & Metabolism, 94(12), 5174-5180. https://doi.org/10.1210/jc.2009-1067

van der Kallen, C. J., van Greevenbroek, M. M., Stehouwer, C. D., & Schalkwijk, C. G. (2009). Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver?Apoptosis, 14(12), 1424-1434. https://doi.org/10.1007/s10495-009-0400-4

Brouwers, M. C., Reesink, K. D., van Greevenbroek, M. M., Meinders, J. M., van der Kallen, C. J., Schaper, N., Hoeks, A. P., & Stehouwer, C. D. (2009). Increased arterial stiffness in familial combined hyperlipidemia. Journal of Hypertension, 27(5), 1009-16. https://doi.org/10.1097/HJH.0b013e32832991fa

Nin, J. W. M., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Chaturvedi, N., Fuller, J. H., & Stehouwer, C. D. (2009). Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.Diabetologia, 52(4), 705-714. https://doi.org/10.1007/s00125-009-1263-5

Jacobs, M., van Greevenbroek, M. M., van der Kallen, C. J., Ferreira, I., Blaak, E. E., Feskens, E. J., Jansen, E. H., Schalkwijk, C. G., & Stehouwer, C. D. (2009). Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.European Journal of Clinical Investigation, 39(6), 437-444. https://doi.org/10.1111/j.1365-2362.2009.02129.x

Scheijen, J. L. J. M., van de Waarenburg, M. P., Stehouwer, C. D., & Schalkwijk, C. G. (2009). Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection.Journal of Chromatography B, 877(7), 610-614. https://doi.org/10.1016/j.jchromb.2009.01.022

Theuwissen, E., Plat, J., van der Kallen, C. J., van Greevenbroek, M. M., & Mensink, R. P. (2009). Plant stanol supplementation decreases serum triacylglycerols in subjects with overt hypertriglyceridemia.Lipids, 44(12), 1131-1140. https://doi.org/10.1007/s11745-009-3367-6

Persson, F., Rossing, P., Reinhard, H., Juhl, T., Stehouwer, C. D., Schalkwijk, C., Danser, A. J., Boomsma, F., Frandsen, E., & Parving, H. H. (2009). Renal effects of aliskiren compared to and in combination with irbesartan in patients with type 2 diabetes, hypertension and albuminuria. Diabetes Care, 32(10), 1873-1879. https://doi.org/10.2337/dc09-0168

Plat, A. W., Stoffers, H. E. J. H., de Leeuw, P. W., van Schayck, C. P., Soomers, F. L., Kester, A. D. M., Aretz, K., & Kroon, A. A. (2009). The association between arterial stiffness and the angiotensin II type 1 receptor (A1166C) polymorphism is influenced by the use of cardiovascular medication. Journal of Hypertension, 27(1), 69-75. https://doi.org/10.1097/hjh.0b013e328317f215

Rennenberg, R. J. M. W., Kessels, A. G. H., Schurgers, L. J., van Engelshoven, J. M. A., de Leeuw, P. W., & Kroon, A. A. (2009). Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vascular health and risk management, 5(1), 185-97. https://doi.org/10.2147/vhrm.s4822

Wouters, K., van Gorp, P. J. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lutjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., van Bilsen, M., Sverdlov, R., & Hofker, M. H. (2008). Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology, 48(2), 474-486. https://doi.org/10.1002/hep.22363

Vanschoonbeek, K., Wouters, K., van der Meijden, P. E., van Gorp, P. J. J., Feijge, M. A., Herfs, M., Schurgers, L. J., Hofker, M. H., de Maat, M. P., & Heemskerk, J. W. (2008). Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice.Arteriosclerosis Thrombosis and Vascular Biology, 28(11), 2023-2029. https://doi.org/10.1161/ATVBAHA.107.156992

Persson, F., Rossing, P., Hovind, P., Stehouwer, C. D. A., Schalkwijk, C. G., Tarnow, L., & Parving, H. H. (2008). Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 diabetes and Microalbuminuria (IRMA 2) study. Scandinavian Journal of Clinical & Laboratory Investigation, 68, 731-8. https://doi.org/10.1080/00365510802187226

Gruden, G., Bruno, G., Cahturvedi, N., Burt, D., Schalkwijk, C. G., Pinach, S., Stehouwer, C. D. A., Witte, D. R., Fuller, J. F., & Cavallo Perin, P. (2008). EURODIAB Prospective Complications Study Group Serum HSP27 and diabetes complications in the Eurodiab Prospective Complications Study: a novel circulating marker for diabetic neuropathy. Diabetes, 57, 1966-70. https://doi.org/10.2337/db08-0009

Du, H., van der A, D. L., van Bakel, M. M., van der Kallen, C. J., Blaak, E. E., van Greevenbroek, M. M., Jansen, E. H., Nijpels, G., Stehouwer, C. D., Dekker, J. M., & Feskens, E. J. M. (2008). Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. American Journal of Clinical Nutrition, 87(3), 655-61. https://doi.org/10.1093/ajcn/87.3.655

Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U. M., Pedersen, O., Parving, H. H., & Vaag, A. A. (2008). Impact of metformin versus repaglinide on non-glycemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. European Journal of Endocrinology, 158, 631-41. https://doi.org/10.1530/EJE-07-0815

Astrup, A., Tarnow, L., Pietraszek, L., Schalkwijk, C. G., Stehouwer, C. D. A., Parving, H. H., & Rossing, P. (2008). Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years Association with mortality and decline of glomerular filtration rate. Diabetes Care, 31, 1170-6. https://doi.org/10.2337/dc07-1960

Brouwers, O., Teerlink, T., van Bezu, J., Barto, R., Stehouwer, C. D. A., & Schalkwijk, C. G. (2008). Methylglyoxal and methylglyoxal-arginine adducts do not directly inhibit endothelial nitric oxide synthase. Annals of the New York Academy of Sciences, 1126, 231-4. https://doi.org/10.1196/annals.1433.017

Baumann, M., Stehouwer, C. D. A., Scheijen, J. L. J. M., Heemann, U., Struijker Boudier, H. A. J., & Schalkwijk, C. G. (2008). N{epsilon}-(carboxymethyl)lysine during the early development of hypertension. Annals of the New York Academy of Sciences, 1126, 201-4. https://doi.org/10.1196/annals.1433.004

van den Berg, S. W., Jansen, E. H., Kruijshoop, M., Beekhof, P. K., Blaak, E., van der Kallen, C. J., van Greevenbroek, M. M., & Feskens, E. J. (2008). Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study). Diabetic Medicine, 25(2), 186-93. https://doi.org/10.1111/j.1464-5491.2007.02328.x

Wang, P., Smit, E., Brouwers, M., Goossens, G. H., van der Kallen, C. J. H., van Greevenbroek, M. M. J., & Mariman, E. (2008). Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot.European Journal of Endocrinology, 159(6), 713-718. https://doi.org/10.1530/EJE-08-0521

Brouwers, M. C., Dekker, J. M., van Greevenbroek, M. M., van der Kallen, C. J., Heine, R. J., de Bruin, T. W., & Stehouwer, C. D. (2008). Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study. Diabetic Medicine, 25(9), 1121-4. https://doi.org/10.1111/j.1464-5491.2008.02524.x

Persson, F., Rossing, P., Schjoedt, K. J., Juhl, T., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Boomsma, F., Frandsen, E., & Parving, H. H. (2008). Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney International, 73, 1419-25. https://doi.org/10.1038/ki.2008.68

Meex, S. J., van Vliet-Ostaptchouk, J. V., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Schalkwijk, C. G., Feskens, E. J. M., Blaak, E. E., Wijmenga, C., Hofker, M. H., Stehouwer, C. D., & de Bruin, T. W. (2008). Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: Association study in 2000 Dutch Caucasians. Molecular Genetics and Metabolism, 94(3), 352-355. https://doi.org/10.1016/j.ymgme.2008.03.011

Verberk, W. J., Kroon, A. A., Lenders, J. W. M., Kessels, A. G. H., van Montfrans, G. A., Smit, A. J., van der Kuy, P.-H. M., Nelemans, P. J., Rennenberg, R. J. M. W., Grobbee, D. E., Beltman, F. W., Joore, M. A., Brunenberg, D. E. M., Dirksen, C., Thien, T., de Leeuw, P. W., & Home Versus Office Measurement, Reduction of Unnecessary Treatment Study Investigators (2007). Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension, 50(6), 1019-25. https://doi.org/10.1161/HYPERTENSIONAHA.107.094193

Dielis, A. W. J. H., Smid, M., Spronk, H. M. H., Houben, A. J. H. M., Hamulyák, K., Kroon, A. A., Ten Cate, H., & de Leeuw, P. W. (2007). Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients. Journal of Thrombosis and Haemostasis, 5(7), 1509-15. https://doi.org/10.1111/j.1538-7836.2007.02577.x

Meex, S. J., van Greevenbroek, M. M. J., Ayoubi, T. A., Vlietinck, R., van Vliet-Ostaptchouk, J. V., Hofker, M. H., Vermeulen, V. M., Schalkwijk, C. G., Feskens, E. J., Boer, J. M., Stehouwer, C. D., van der Kallen, C. J. H., & de Bruin, T. W. (2007). Activating transcription factor 6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians. Journal of Clinical Endocrinology & Metabolism, 92(7), 2720-2725. https://doi.org/10.1210/jc.2006-2280

Bruynzeel, A. M., Abou el Hassan, M. A., Schalkwijk, C., Berkhof, J., Bast, A., Niessen, H. W. M., & van der Vijgh, W. J. (2007). Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. British Journal of Cancer, 96(6), 937-943. https://doi.org/10.1038/sj.bjc.6603640

Schindhelm, R. K., Alssema, M., Scheffer, P. G., Diamant, M., Dekker, J. M., Barto, R., Nijpels, G., Kostense, P. J., Heine, R. J., Schalkwijk, C. G., & Teerlink, T. (2007). Fasting and postprandial glycoxidative and lipoxidative stress are increased in women with type 2 diabetes. Diabetes Care, 30(7), 1789-1794. https://doi.org/10.2337/dc06-2585

Ciapaite, J., Bakker, S. J., van Eikenhorst, G., Wagner, M. J., Teerlink, T., Schalkwijk, C. G., Fodor, M., Ouwens, DM., Diamant, M., Heine, R. J., Westerhoff, H. V., & Krab, K. (2007). Functioning of oxidative phosphorylation in liver mitochondria of high-fat diet fed rats. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1772(3), 307-316. https://doi.org/10.1016/j.bbadis.2006.10.018

van Greevenbroek, M. M., Vermeulen, V. M., Feskens, E. J., Evelo, C. T., Kruijshoop, M., Hoebee, B., van der Kallen, C. J., & de Bruin, T. W. (2007). Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus. Diabetic Medicine, 24(5), 498-504. https://doi.org/10.1111/j.1464-5491.2007.02109.x

Ciapaite, J., van Bezu, J., van Eikenhorst, G., Bakker, S. J., Teerlink, T., Diamant, M., Heine, R. J., Krab, K., Westerhoff, H. V., & Schalkwijk, C. G. (2007). Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, 1771(2), 147-154. https://doi.org/10.1016/j.bbalip.2006.12.005

Hermans, M. M. H., Kooman, J. P., Meinders, J. M., van der Sande, F. M., Brandenburg, V., Ketteler, M., Damoiseaux, J. G. M. C., Cohen Tervaert, J. W., Ferreira, I., Konings, C. J. A. M., Rensma, P. L., Gladziwa, U., Kroon, A. A., Hoeks, A. P. G., Stehouwer, C. D. A., & Leunissen, K. M. L. (2007). Spatial inhomogeneity of common carotid artery intima media is increased in dialysis patients and is independently related to antibodies to oxidized-LDL and serum fetuin-A concentration. Nephrology Dialysis Transplantation, 22 (4), 1205-1212. https://doi.org/10.1093/ndt/gfl750

Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Frandsen, M., Smidt, U. M., Pedersen, O. F., Parving, H. H., & Vaag, A. (2007). Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obesity & Metabolism, 9 (3), 394-407. https://doi.org/10.1111/j.1463-1326.2007.00713.x

Verberk, W. J., Kroon, A. A., Jongen-Vancraybex, H. A., & de Leeuw, P. W. (2007). The applicability of home blood pressure measurement in clinical practice: a review of literature. Vascular health and risk management, 3(6), 959-966. https://doi.org/10.2147/vhrm.s12187432

Wang, P., van Greevenbroek, M. M., Bouwman, F. G., Brouwers, M. C., van der Kallen, C. J. H., Smit, E., Keijer, J., & Mariman, E. C. (2007). The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflugers Archiv-European Journal of Physiology, 454(6), 971-976. https://doi.org/10.1007/s00424-007-0262-y

Shiri-Sverdlov, R., Wouters, K., van Gorp, P. J. J., Gijbels, M. J. J., Noel, B., Buffat, L., Staels, B., Maeda, N., van Bilsen, M., & Hofker, M. H. (2006). Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. Journal of Hepatology, 44(4), 732-741. https://doi.org/10.1016/j.jhep.2005.10.033

van Boxtel, M. P. J., Henskens, L. H. G., Kroon, A. A., Hofman, P. A. M., Gronenschild, E. H. B. M., Jolles, J., & de Leeuw, P. W. (2006). Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. Journal of Human Hypertension, 20, 5-13. https://doi.org/10.1038/sj.jhh.1001934

Schalkwijk, C. G., & Stehouwer, C. D. (2006). PAI-1 inhibition in obesity and the metabolic syndrome: a promising therapeutic strategy. Thrombosis and Haemostasis, 96(6), 698-699. https://doi.org/10.1160/th06-11-0631

Schalkwijk, C. G., Chaturverdi, N., Schram, M. T., Fuller, J. H., & Stehouwer, C. D. A. (2006). Re: Adiponectin and renal function: pitfalls of renal function estimates and corrections for BSA. Journal of Clinical Endocrinology & Metabolism.

Kooman, J. P., Schalkwijk, C. G., & Konings, C. J. A. M. (2006). The increase in plasma levels of Nepsilon-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1. Peritoneal Dialysis International, 26(3), 410-411. https://doi.org/10.1177/089686080602600322

Dielis, A. W. J. H., Smid, M., Spronk, H. M. H., Hamulyak, K., Kroon, A. A., ten Cate, H., & de Leeuw, P. W. (2005). The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems. Hypertension, 46(6), 1236-42. https://doi.org/10.1161/01.HYP.0000193538.20705.23

Plat, A. W., te Wierik, M. J. M., Kroon, A. A., Schouten, H. J. A., van den Akker, M., van Schayck, C. P., de Leeuw, P. W., Hajema, K.-J., & Stoffers, H. E. J. H. (2005). Regional differences in cardiovascular risk factor profile cannot fully explain differences in cardiovascular morbidity in the Netherlands: a comparison of two urban areas. Netherlands Journal of Medicine, 63(8), 309-315.

Schram, M. T., Schalkwijk, C. G., Bootsma, A. H., Fuller, J. H., Chaturvedi, N., & Stehouwer, C. D. (2005). Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension, 46(1), 232-237. https://doi.org/10.1161/01.HYP.0000164574.60279.ba

Schram, M. T., van Ittersum, F. J., Spoelstra-de Man, A. M., van Dijk, R. A. J. M., Schalkwijk, C. G., Ijzerman, R. G., Twisk, J. W. R., & Stehouwer, C. D. A. (2005). Aggressive antihypertensive therapy based on hydrochlorothiazide candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals effects on albumin excretion endothelial function and inflammation in a double-blind randomized cl. Journal of Human Hypertension, 19, 429-437. https://doi.org/10.1038/sj.jhh.1001812

Hommels, M. J., van der Ven, A., Kroon, A. A., Kessels, A. G. H., van Dieijen-Visser, M. P., van Engelshoven, J. M. A., Bruggeman, C. A., & de Leeuw, P. W. (2005). C-reactive protein, atherosclerosis and kidney function in hypertensive patients. Journal of Human Hypertension, 19(7), 521-526. https://doi.org/10.1038/sj.jhh.1001878